Thursday, February 9, 2012 Last update: 6:33 PM
The Best of U.S. Company Technology News
Submit Company story ideas to FreshNews.com. See our complete guidelines.
Trade Events
Advaxis, Inc.
News articles for Advaxis, Inc.:
Thursday, February 9, 2012
- Advaxis to Present at the 14th Annual BIO CEO & Investor ConferenceAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that Tom ... read more
Thursday, January 26, 2012
- Advaxis CEO Tom Moore Interviewed by OneMedPlace Regarding Preliminary DataAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reports that Thomas Moore, ... read moreREPEAT/Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical CancerAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on ... read more
Wednesday, January 25, 2012
- Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical CancerAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on ... read more
Wednesday, January 11, 2012
- Dosing Begins for GOG US Cervical Cancer Study Evaluating ADXS-HPVAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced at the OneMedForum ... read more
Friday, January 6, 2012
- Advaxis to Present at 5th Annual OneMedForum San Francisco 2012Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that Tom ... read more
Friday, December 30, 2011
- Advaxis Receives Additional FinancingAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a ... read more
Friday, December 16, 2011
- Advaxis Reports Preliminary Data from ADXS-HPV Phase 2 Trial in Patients with Recurrent/Refractory Cervical Cancer at AACR IndiaAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on ... read more
Wednesday, November 23, 2011
- Advaxis Completes Pre-IND Meeting for ADXS-HER2Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, completed a pre-IND (Investigational ... read more
Tuesday, November 15, 2011
- Advaxis Licenses Novel Antigen for Severe Breast Cancer and Other Tumor TypesAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has exclusively licensed the ... read more
Tuesday, October 18, 2011
- Advaxis Announces Notice of Allowance of US Patent for ADXS-HPV ImmunotherapyAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced that the ... read more
Monday, October 17, 2011
- Advaxis to Present at the 2011 10th Annual BIO Investor Forum on October 25thAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced that Tom ... read more
Thursday, October 13, 2011
- Advaxis ADXS-HPV Project Selected as One of the Windhover and Campbell Alliance 2011 Top 10 Most Interesting Oncology Projects to WatchAdvaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been chosen by ... read more
Tuesday, October 11, 2011
- Advaxis Granted Pre-IND Meeting with FDA for ADXS-HER2, an Immunotherapy for HER2 Expressing CancersAdvaxis, Inc., (OTCBB:ADXS) a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational ... read more
Tuesday, September 6, 2011
- Advaxis Will Present at the Rodman & Renshaw 13th Annual Healthcare Conference on September 13th, 2011Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that the ... read more